Cargando…
MicroRNAs in blood act as biomarkers of colorectal cancer and indicate potential therapeutic targets
Association studies have linked alterations of blood‐derived microRNAs (miRNAs) with colorectal cancer (CRC). Here, we performed a microarray‐based comparison of the profiles of 2549 miRNAs in 80 blood samples from healthy donors and patients with colorectal adenomas, colorectal diverticulitis and C...
Autores principales: | Stang, Axel, Weilert, Hauke, Lipp, Michael J., Oldhafer, Karl J., Hoheisel, Jörg D., Zhang, Chaoyang, Bauer, Andrea S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410571/ https://www.ncbi.nlm.nih.gov/pubmed/34288395 http://dx.doi.org/10.1002/1878-0261.13065 |
Ejemplares similares
-
Impact of Systemic Therapy and Recurrence Pattern on Survival Outcome after Radiofrequency Ablation for Colorectal Liver Metastases
por: Stang, Axel, et al.
Publicado: (2016) -
Selection criteria for radiofrequency ablation for colorectal liver metastases in the era of effective systemic therapy: a clinical score based proposal
por: Stang, Axel, et al.
Publicado: (2014) -
Can microRNAs act as biomarkers of aging?
por: Kashyap, Luv
Publicado: (2011) -
Unresectable Hepatic Metastasis of Uveal Melanoma: Hepatic Chemosaturation with High-Dose Melphalan—Long-Term Overall Survival Negatively Correlates with Tumor Burden
por: Brüning, R., et al.
Publicado: (2020) -
MicroRNAs as Biomarkers in Colorectal Cancer
por: Masuda, Takaaki, et al.
Publicado: (2017)